• Phoenix Rising needs funds to operate: please consider donating to support PR

From British Medical Journal: Editorials The long wait for a breakthrough in chronic fatigue syndrom

The long wait for a breakthrough in chronic fatigue syndrome

BMJ2015; 350 doi: http://dx.doi.org/10.1136/bmj.h2087 (Published 05 May 2015)Cite this as: BMJ 2015;350:h2087

There hasn’t been much good news for patients with the prevalent but enigmatic disorder chronic fatigue syndrome (also referred to as myalgic encephalomyelitis). Over decades, research into the pathophysiology has failed to find convincing evidence of either persistent infection or immunological, endocrine, or metabolic change, and has rejected simplistic notions of depression (typical or atypical) or primary sleep disorder. Several notable “breakthroughs” have failed independent replication. The most noteworthy is the recent rise and fall of xenotropic murine leukaemia virus related virus (XMRV) as the cause, which was ultimately established as a murine DNA laboratory contaminant.1 Similarly, an exhaustive array of randomised controlled trials seeking curative outcomes from antiviral, immunological, hormonal, antidepressant, and many other therapies have failed to show any benefit over placebo, or failed the replication test.

Where then is the progress? Firstly, there is reproducible evidence implicating certain infections as a trigger—notably, infectious mononucleosis caused by Epstein-Barr virus, but also infection with other pathogens.2 Secondly, there is clear evidence that a substantial proportion of patients have a coexisting mood disorder, and sometimes a sleep-wake disorder, and that these conditions may exacerbate or perpetuate

anyone has full access?

Comments

He's not a member of Research Gate, but I'd consider emailing him and asking for the full text. Sometimes authors will do that if you ask nicely. :)
 

Blog entry information

Author
seid1001
Views
163
Comments
4
Last update

More entries in User Blogs